The Effect of Inhibitory Antibodies on Acute Treatment of Bleeding Episodes with OBI-1, an Antihemophilic Factor VIII (recombinant), Porcine Sequence, in Patients with Acquired Hemophilia A

被引：0
|
作者：
Farin, Heinrich D. [1 ]
Novack, Aaron [1 ]
Mo, Min [1 ]
Bourgeois, Christelle [2 ]
Horling, Frank M. [2 ]
Ewenstein, Bruce M. [1 ]
机构：
[1] Baxter Healthcare Corp, Westlake Village, CA USA
[2] Baxter BioSci, Vienna, Austria
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Recombinant Porcine Factor VIII, Obi-1, Successfully Controlled Gastrointestinal Bleeding in a Patient with Acquired Hemophilia A
    Riaz, Muhammad Kashif
    Girnius, Saulius
    Palascak, Joseph Edward
    BLOOD, 2015, 126 (23)
  • [2] Overview of the structure and manufacturing process for OBI-1, a recombinant porcine sequence, factor VIII for the treatment of acquired hemophilia A
    Wojciechowski, Peter
    Lai, Chee Kong
    Xiong, Yi
    Deer, Frank
    HAEMOPHILIA, 2014, 20 : 181 - 181
  • [3] The Benefit of FVIII Measurement: Tailored Treatment with Obi-1, a Recombinant Porcine Sequence Factor VIII, in Subjects with Acquired Hemophilia a
    Oladapo, Abiola
    Epstein, Joshua
    Novack, Aaron
    Farin, Heinrich D.
    BLOOD, 2014, 124 (21)
  • [4] Treatment of serious bleeds with an antihaemophilic factor VIII (recombinant), porcine sequence (OBI-1) in patients with acquired haemophilia A
    Kruse-Jarres, R.
    St-Louis, J.
    Greist, A.
    Shapiro, A.
    Smith, H.
    Chowdary, P.
    Drebes, A.
    Gomperts, E.
    Bourgeois, C.
    Mo, M.
    Novack, A.
    Farin, H.
    Ewenstein, B.
    HAEMOPHILIA, 2015, 21 : 62 - 62
  • [5] Recombinant porcine sequence factor VIII (OBI-1): Results from a prospective clinical study investigating the treatment of serious bleeds in patients with acquired hemophilia A
    Kruse-Jarres, R.
    St-Louis, J.
    Greist, A.
    Shapiro, A.
    Smith, H.
    Chowdary, P.
    Drebes, A.
    Gomperts, E.
    Chapman, M.
    Mo, M.
    Novack, A.
    Farin, H.
    HAEMOPHILIA, 2014, 20 : 1 - 1
  • [6] OBI-1, porcine recombinant Factor VIII for the potential treatment of patients with congenital hemophilia A and alloantibodies against human Factor VIII
    Toschi, Vincenzo
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2010, 12 (05) : 617 - 625
  • [7] TREATMENT OF SERIOUS BLEEDS IN A PROSPECTIVE CLINICAL TRIAL WITH A B-DOMAIN DELETED RECOMBINANT PORCINE SEQUENCE FACTOR VIII (OBI-1) IN PATIENTS WITH ACQUIRED HEMOPHILIA A
    Kruse-Jarres, Rebecca
    St-Louis, Jean
    Greist, Anne
    Shapiro, Amy
    Smith, Hedy
    Chowdary, Pratima
    Drebes, Anja
    Gomperts, Edward
    Chapman, Miranda
    Mo, Min
    Novack, Aaron
    Farin, Heinrich
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (06) : E41 - E42
  • [8] Efficacy and safety of OBI-1, an antihaemophilic factor VIII (recombinant), porcine sequence, in subjects with acquired haemophilia A
    Kruse-Jarres, R.
    St-Louis, J.
    Greist, A.
    Shapiro, A.
    Smith, H.
    Chowdary, P.
    Drebes, A.
    Gomperts, E.
    Bourgeois, C.
    Mo, M.
    Novack, A.
    Farin, H.
    Ewenstein, B.
    HAEMOPHILIA, 2015, 21 (02) : 162 - 170
  • [9] Treatment Of Serious Bleeds With a B-Do Domain Deleted Recombinant Porcine Sequence Factor VIII (OBI-1) In Patients With Acquired Hemophilia A: A Prospective Clinical Trial
    Kruse-Jarres, Rebecca
    St Louis, Jean
    Greist, Anne
    Shapiro, Amy D.
    Smith, Hedy
    Chowdary, Pratima
    Drebes, Anja B.
    Gomperts, Edward D.
    Chapman, Miranda
    Mo, Min
    Novack, Aaron
    Farin, Heinrich D.
    BLOOD, 2013, 122 (21)
  • [10] Efficacy and safety of B-domain deleted recombinant porcine factor VIII (OBI-1) in the treatment of acquired hemophilia A: interim results
    Greist, A.
    Shapiro, A.
    Kruse-Jarres, R.
    St Louis, J.
    Smith, H.
    Gomperts, E.
    HAEMOPHILIA, 2012, 18 : 1 - 1
12345